TOXINS 2024: Galderma s Phase III RelabotulinumtoxinA Results Demonstrate Positive Efficacy and Long Duration of Effect When Treating Frown Lines and Crow s Feet Simultaneously streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Galderma announced today positive topline results from the phase III READY3 clinical trial investigating the use of RelabotulinumtoxinA for the treatment of glabellar lines frown lines and lateral canthal lines crows feet either alone singlearea or simultaneously.